Early proliferation of PD-1+ CD8 T cells in peripheral blood as predictive of response to PD-1 inhibition for patients with advanced NSCLC.

e20648Background: Anti PD-1 and PDL-1 antibodies are now established immune targeted therapiesfor a subset of patients with advanced non-small cell lung cancer (NSCLC). There is a need for predict...